Rigel Pharmaceuticals | RIGL - Interest Income


Rigel Pharmaceuticals reported $0.7 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Arrowhead Research USD 16.93M 66K Jun/2026
AstraZeneca USD 80M 7M Jun/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.65M 262K Mar/2026
MacroGenics USD 1.55M 26K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
Veracyte USD 3.48M 4K Mar/2026